Introduction
Serotonin (5HT) is a classic neurotransmitter produced from the essential amino acid tryptophan and can be found in both the peripheral and central nervous system (CNS) [30, 52] . In the rodent brain development serotonin has been detected as early as embryonic day 10.5 (E10.5) [5, 29] . During development of CNS, it has been described as a trophic factor influencing a broad range of developmental processes such as cell division, neuronal migration, differentiation, synaptogenesis and critical periods of plasticity [2] . In the mature brain, serotonin has been implicated in the modula-tion of mood, cognition, attention, arousal, stress response and as a neuromodulator of circuitry plasticity [8, 27] .
One of the most essential aspects of 5-HT homeostasis is the clearance of extracellular 5-HT through serotonin transporter (5-HTT) which interrupts its postsynaptic actions through neuronal reuptake [33] . Indeed, since its discovery, 5-HTT has received considerable attention because it represents the primary target of several prescribed modern antidepressants [35] . In addition, alteration in 5-HTT functional status has been associated with a wide range of psychiatric disorders such as autism, anxiety and depression [22, 47] .
Major depression is a common and debilitating mental disorder and it is expected to be the second leading cause of disability worldwide by 2020 [22] . The prevalence of depression is more frequent between women than men with an incidence from 5% to 9% for women [13] . In addition, studies have shown an increased http://dx.doi.org/10.1016/j.neulet.2017.07.047 0304-3940/© 2017 Elsevier B.V. All rights reserved. rate of depression onset during pregnancy, affecting 17% of women, frequently requiring pharmacological interventions [6, 11] .
Despite being a popular anti depressive drug, little is known about the possible adverse effects to the fetal brain development after a chronic exposure to selective serotonin reuptake inhibitors (SSRI) antidepressants [1, 36] . Indeed, fluoxetine has been widely used during pregnancy and lactation and is the only SSRI approved for pediatric use [21, 23] . Studies have shown that children under prenatal exposure to antidepressants present increased risks of abnormal social and emotional behaviors such as social withdrawal, anxiety and depression, aggression and attention deficit/hyperactivity [37, 38] .
Several studies have focused on the molecular mechanisms involved in major depression and their modulation by SSRIs. In mouse models of postpartum depression, offspring exhibited depression like-behaviors during different periods of development with a continuous deficit in the AKT signaling in the hippocampus [53] . Moreover, it has been shown that ERK 1/2 levels are down-regulated in different models of depression [17, 42] . Also, a reduction in ERK1/2 levels was observed in the prefrontal cortex and hippocampus of suicide subjects [11] .
In the past few years, it has been described that the chronic treatment with fluoxetine during early postnatal development of the rat visual system produces abnormal patterns of topographical mapping and abnormally increased plasticity in subcortical visual pathways [3] . Similar results have been described by studies using serotonin transporter (5-HTT) or monoamine oxidase A (MAOA) knockout models, which resulted in abnormal cortical cytoarchitecture and topographical patterning disruption of the somatosensory barrel and visual cortex [8, 34] .
Despite this body of evidence, little is known about the ontogenesis of 5-HTT and the influence of SSRIs on 5-HTT content and the impact on downstream serotonin signaling pathways in the developing brain. In the present study we describe, using immunohistochemistry and western blot techniques, the time course of 5-HTT ontogenesis in the rat visual system and the resultant effect of a chronic treatment with fluoxetine on 5-HTT immunoreactivity and signaling pathways during the first and the second postnatal weeks, which is roughly correspondent to the third trimester of human gestation [32] in comparison to similar treatment in juvenile animals.
Materials and methods
Lister Hooded rats were used for neuroanatomical and biochemical assays. Care was taken to achieve proper anesthesia during all surgical interventions. Studies were designed to minimize the number of animals used. All animal use procedures were in strict accordance with The National Institutes of Health Guide for the Care and Use of Laboratory Animals and EC Directive 86/609/EEC for animal experiments. The experimental protocol has been approved by the local Animal Care Committee under protocol 12/009 of Federal Fluminense University. Regarding group formation, N reefers to number of animals from different litters. Animals from the same mother were randomly distributed to control and experimental groups. For immunohistochemistry experiments we used 5 animals/group; for western blot experiments (pERK and pAKT), we used 4 animals/experimental group.
Fluoxetine treatment
Neonate rats were treated with daily injections of fluoxetine (10 mg/kg, ip − Bastos et al. [3] ) from the day of birth to post-natal day 14 (PND0-14) or from PND21 to PND42. Control matchedgroups received saline injection as a vehicle (NaCl 0.9%, i.p.).
Labeling of 5-HTT immunoreactivity in the superior colliculus
Lister Hooded rats were deeply anaesthetized with isoflurane (Virbac, Brazil) and transcardially perfused with saline (0.9% NaCl) followed by 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.2. The brains were removed and cryoprotected overnight in a solution of 20% sucrose. Coronal sections of superior colliculus (20 m) were cut on a freezing microtome (Leica). Sections were incubated with a rabbit anti-5-HTT antibody (1:1000, Sigma, St Louis, MO, USA) diluted in PBS containing 10% normal goat serum (NGS) and 0.25% Triton. After 24 h, the slices were incubated with goat anti-rabbit IgG (1:200) for 2 h, followed by ABC Elite complex (1:50, Vector Labs), and revealed with diaminobenzidine (DAB) as described [41] . Sections were dehydrated in alcohol, cleared in xylene and coverslips mounted with Entelan (Merck). The immunoreactive profiles were analyzed in a Leica DM 2500 microscope under bright field optics. Images were captured with a digital camera coupled to the microscope stage.
Western blot analysis
Superior colliculi of animals at PND 14 or PND 42 treated with either fluoxetine or vehicle injections were dissected and homogenized in ice-cold buffer containing SDS and homogenized in ice-cold 50 mM Tris-HCl pH 7.4. The resulting homogenates were centrifuged at 15,000g for 10 min at 4 • C and the supernatants used for protein concentration determination and analysis (Bradford, 1976) . Fifty g protein/lane was separated by SDS/PAGE (10% with a 4% concentrating gel) and electro-transferred to PVDF membranes (Amersham Bioscience). After blocking for 2 h at room temperature with 5% powder milk in Tris-buffered saline, pH 7.6 containing 0.1% Tween 20 (TBS-T), the membranes were incubated overnight at 4 • C with rabbit anti pERK antibody (1:500 -Oncogene) or rabbit anti pAKT antibody (1:1000, Cell Signaling). Membranes were incubated with secondary HRP-conjugated antibody (1:5000 -Amersham Biosciences, USA) in TBS-T during 2 h at room temperature and revealed using the ECL plus chemiluminescent kit (Amersham Biosciences) with a Chemi Express system (Loccus). In order to verify whether all lanes contained an equal loading of proteins, membranes were stripped and re-probed with ERK antibody (anti-rabbit, 1:1000 -Santa Cruz). Densitometric analyses were performed with Scion Image for Windows software (Scion Corp., Frederick, Md., USA).
Statistical analysis
Graphs were plotted using GraphPad Prism 5.0 software and the statistical analysis performed using the non-parametric Mann-Whitney test. Differences were considered significant when p < 0.05.
Results

Serotonin transporter ontogenesis
Serotonin has been shown to affect the development of mammalian nervous system and 5-HTT is a major mechanism in regulating extracellular serotonin levels [18, 26] . To access the influence of serotonin transporter availability during development of the superior colliculus, we used anti-5-HTT antibodies at different postnatal days (Fig. 1) . In all stages, the pattern of immunoreactivity was characterized by fibers and varicosities. At birth, animals presented the weakest immunoreactivity to 5-HTT (Fig. 1A) . A progressive increase in 5-HTT immunoreactivity was observed after eye opening, between postnatal day 14 (PND14) and PND42 (Fig. 1C,  D and E) . In adults, 5-HTT immunoreactivity decreased relative to juvenile rats (PND 14 ∼ 42) but immunoreactivity was higher than that observed at PND 0.
Effects of fluoxetine treatment upon 5-HTT immunoreactivity and downstream signaling pathways
It's well documented that the retinotectal projections can be reorganized even in adulthood, although this plastic reorganization is less intense after the critical period of development [48] . Our group has already shown that the fluoxetine treatment induces plasticity of retinotectal pathway both during and after the critical period of retinocollicular development [3] . In the present study, we investigated the effects of a neonatal (PND0-14) of juvenile (PND21-42) chronic fluoxetine treatment on the immunoreactivity of serotonin transporter in the visual layers of the superior colliculus at either PND 14 or 42. We found that fluoxetine treatment either between PND0-14 ( Fig. 2B) or PND21-42 (Fig. 2D ) decreased 5-HTT immunoreactivity when compared to control matched groups ( Fig. 2A,C) . In fact, Fig. 2 shows that while the pattern of 5-HTT immunoreactivity was different in fluoxetine-treated groups compared to controls with less fibers and varicosities expressing 5-HTT for all ages studied, antibody-labeled fibers and varicosities did not show a dramatic change of expression level.
Since serotonin effects are partially mediated by Akt and ERK signaling pathways [10] , we decided to evaluate the influence of fluoxetine upon these signaling mediators in different periods of development. Chronic fluoxetine treatment during early (PND 0-14) or late development (PND 21-42) increased the phosphorylation of AKT (Fig. 3A-B) and of both ERK 42 and ERK 44 isoforms (Fig. 3C-D ) when compared to saline matched-groups suggesting that those signaling pathways may be involved in the modifications in 5-HTT expression induced by fluoxetine.
Discussion
In the present study, we report that the expression of serotonin transporter is modulated during development of the visual system. Specifically, we observed a gradual increase from PND 0 to PND42, most of which after eye opening at PND 14. At the end of the critical period of retinocollicular plasticity at PND 21 (Serfaty et al. [48] ), we observed stable levels of 5-HTT immunoreactivity and, finally, 5-HTT levels were decreased by PND70. Also, we showed that a chronic fluoxetine treatment induces a down-regulation in 5-HTT immunoreactivity which might further increase serotonergic signaling as demonstrated by an up-regulation in the phosphorylation of AKT and ERK pathways. In the present study, we used both males and females, but it is important to point out that puberty in rats occurs after PND 28. Therefore, only data from animals at PND 42 and 70 could be affected by sex. However, western blot experiments did not show differences related to age. And immunohistochemistry did not show any difference, at least between animals at PND 21 and PND 42. Furthermore, the literature does not relate any study relating sex differences and serotonin transporter expression in the visual system. Trazi et al. [50] reported a similar developmental pattern of both 5-HTT and DAT in the striatum and nucleus accumbens between PND7 and PND60. In addition, in different brain areas, 5-HTT and DAT expression presented a similar triphasic profile with a gradual increase between embryonic stages until PND21 followed by a small decline around the third and fourth postnatal week, then becoming stable in adulthood [14] . This pattern of 5-HTT expression could be the key element modulating serotonergic signaling in the brain.
Several studies reported that use-dependent plasticity depends on serotonergic signaling during early development [3, 49] . It is well known that serotonin modulates plasticity and the construction of brain circuits as well as a variety of behavioral functions related to emotions and cognition [16] . Different studies manipulating serotonin levels on different periods of development have shown the importance of correct levels of this neurotransmitter for the proper development of different sensory connections [3, 15] . Additionally, it has already been shown that 5-HTT is also transiently expressed in non-serotonergic axons during a limited period of development in order to control serotonin levels which act as trophic factor in the immature brain [8, 51] .
Depression is a common disorder during pregnancy and SSRI are frequently prescribed during this period [37] . Since antidepressants are able to cross the placenta and can be transported via breast milk, both the fetus and newborn children are potentially affected by these drugs [36] . Also, SSRIs are prescription antidepressants commonly used throughout childhood and adolescence [12] . In the present study we show that fluoxetine induces a reduction in 5-HTT immunoreactivity during early (PND 0-14) and late development (PND 21-42) (Fig. 2) which barely corresponds to perinatal/childhood and adolescence periods of human development. Other studies have shown that different psychoactive drugs acting on monoaminergic systems may lead to an overall reduction of 5-HTT expression and it has been suggested that 5-HTT internalization might be a crucial regulatory mechanism in the process of neuronal response to treatment of depression [20, 24, 44] . Accordingly, the perinatal reduction of 5-HTT induced either by fluoxetine or 5-HTT knockout results in an overall development delay [25] . Indeed, hyperserotonemia induced by antidepressants exposure during pregnancy has been associated with autism spectrum disorders [40] .
Together these data support that 5-HTT expression/function seems to be important to the maintenance of normal serotonergic signaling. Indeed, fluoxetine administration disrupts the retinotectal topography leading to a topographical expansion of the retinotectal terminal fields both in the developing and in the mature brain and amplifies the lesion-induced plasticity of the intact pathways [3] . Likewise, serotonin increase either through monoamine oxidase A (MAOA) inhibition during the critical period or MAO knockout mice resulted in abnormal barrel formation in the somatosensory rodent cortex [7] . Furthermore, barrel-deficient phenotype of MAOA-KO mice was reverted in a MAO/5HT1B double knockout mice, indicating that overstimulation of 5HT1B is related to abnormal development of barrel fields [45] . It has been recently shown that serotonin levels significantly decrease by birth and 5HT1 receptors have a crucial role in the regulation of the sensory map formation in the visual and somatosensory systems [51] . Thus, the modulation of 5-HTT expression by SSRI during postnatal periods may exert critical effects disturbing the correct brain circuitry formation. Serotonin has also been related to the regulation of synaptogenesis and synaptic pruning [19] and these functions have been described impaired in models of depression [4] . The ERK/MAPK and AKT signaling pathways have been involved in events of synaptic plasticity and remodeling [39] and in the last few years, theses pathways have been associated with depressive disorders [9, 31] and stress [46] . Here we showed that fluoxetine treatment during early and late development of retinocollicular pathways was able to increase both pAKT and pERK1/2 contents in the superior colliculus. In fact, different studies have pointed out that some of the antidepressant effects may be associated with the modulation of those signaling pathways [31, 34] . Indeed a recent study showed that 5-HTT functions could be modulated by AKT activity since the use of AKT inhibitors decrease 5HT uptake through 5-HTT plasma membrane availability [43] . In mouse models of postpartum depression the offspring exhibited a depression like-behaviors during different periods of development with a continuous deficit in the AKT signaling in the hippocampus [17] . Similarly, other study showed an increase in mitogen-activated protein kinase phosphatase −1 (MKP-1) expression, the major negative regulator of the MAPK pathway, with a decrease in ERK 1/2 in the hippocampus of depressed individuals when compared with healthy controls [10] . Our data reinforce the hypothesis that the ERK and AKT pathways are the major candidates responsible for the molecular effects of antidepressants on the regulation of 5-HTT and behavior [28, 42] .
In conclusion we show that 5-HTT expression is regulated during development and that a perinatal fluoxetine treatment decreases the expression of 5-HTT and up regulates AKT and ERK signaling pathways in young and juvenile animals. Together these data suggest that the effects of antidepressant are not only related to the pharmacological blockade of 5-HTT but also include the down regulation of 5-HTT expression itself through several molecular steps that include ERK and AKT pathways. Further experiments are necessary to stablish a clear causal relation between those events.
